Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.110
-0.010 (-0.89%)
At close: Mar 13, 2026, 4:00 PM EDT
1.100
-0.010 (-0.90%)
After-hours: Mar 13, 2026, 7:49 PM EDT
Bionano Genomics Employees
As of December 31, 2024, Bionano Genomics had 100 total employees, including 98 full-time and 2 part-time employees. The number of employees decreased by 244 or -70.93% compared to the previous year.
Employees
100
Change (1Y)
-244
Growth (1Y)
-70.93%
Revenue / Employee
$287,200
Profits / Employee
-$385,870
Market Cap
11.30M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 100 | -244 | -70.93% | 98 | 2 |
| Dec 31, 2023 | 344 | -61 | -15.06% | 344 | 0 |
| Sep 30, 2023 | 388 | -17 | -4.20% | 388 | 0 |
| Dec 31, 2022 | 405 | 106 | 35.45% | 405 | 0 |
| Dec 31, 2021 | 299 | 152 | 103.40% | 299 | 0 |
| Dec 31, 2020 | 147 | 50 | 51.55% | 147 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 355 |
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Precision Optics Corporation | 90 |
| Femasys | 71 |
| Ekso Bionics Holdings | 55 |
| Nephros | 31 |
| NEXGEL | 19 |
BNGO News
- 4 days ago - Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 - GlobeNewsWire
- 14 days ago - Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale - GlobeNewsWire
- 15 days ago - 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders - GlobeNewsWire
- 16 days ago - 11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy - GlobeNewsWire
- 17 days ago - 9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies - GlobeNewsWire
- 4 weeks ago - Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping - GlobeNewsWire
- 5 weeks ago - Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies - GlobeNewsWire
- 3 months ago - Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies - GlobeNewsWire